Genmab — Maj 2020
-
Solids: Amivantamab -really excited about mechanism -many bispecifics have not been successful; this one clearly very active -degrades egfr receptor so that it can't act -also degrades cmet receptor which is often activated and amplified in NSCLC -enahced ADCC so it brings an immune killing component -so mulitple ways in going after the tumor
-
Pensionist. Ja kursen bliver holdt mellem 1970 og 1980. Det kan være en der tager profit, en shorter eller lige mange som vil ind /ud på niveauet. Mon ikke bare aktien tager en puster og fortsætter med de 3000 når der er taget profit. Jeg ville ikke shorte lige inden asco og en evt. partnerdeal men muligvis efter
-
For mig ligner det en algo som styrer et tradinginterval med henblik på akkumulering.
-
Dagsgrafen viser det tydeligt. Ligner klingen på en fukssvans.
-
Genmab Success in the Netherlands is Powered by Innovative Life Sciences Ecosystem https://investinholland.com/success-stories/genmab/
-
Du har ret Helge..har lige haft gang i min sav..:-D
-
Små 60.000 stk igennem en kontrolleret auktion.
-
Lige midt i dagens tradingrange.
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind